Effects of Digital Therapeutic in Whole Process Management of Lung Cancer
Recruiting · NCT06230445 · Interventional (participants receive a specific treatment) · Lead sponsor: Sun Yat-sen University
View the official record on ClinicalTrials.gov →Interventions studied
UHealth digital therapeutic
What this trial is about
This trial will randomize patients into two groups, the treatment group will use the digital therapeutic application named 'UHealth' for the whole process management and the control group will use regular follow-up. The trial aims to look into the difference between quality of life, anxiety/depression index, emergency treatment times, hospital admission rate, treatment compliance, OS, DFS and follow-up cost.
Who can take part
Age range
18 Years to 70 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients with histologically or cytologically confirmed lung cancer;
- Patients have received surgery, neoadjuvant therapy, adjuvant therapy, radiotherapy or other chemotherapy, such as cytotoxic chemotherapy, targeted therapy and immunotherapy;
- ECOG (Performance status) 0-1;
- Patients aged \> 18 years and \< 70 years;
- The patients themselves or their family members are familiar with mobile and internet;
Exclusion criteria
- Patients have disease progression in the screening period;
- Patients with symptomatic brain metastasis;
- Patients with dementia, schizophrenia or other psychological diseases that may affect the cognitive behavior;
- Other medical, mental or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or understand the patient information;
- Women who are pregnant or in the period of breastfeeding.
Where it is running
1 location listed.
- Sun Yat-sen University Cancer Center - Guangzhou, Guangdong, China